GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang AngliKang Pharmaceutical Co Ltd (SZSE:002940) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of May. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Zhejiang AngliKang Pharmaceutical Co EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Zhejiang AngliKang Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.

Competitive Comparison of Zhejiang AngliKang Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang AngliKang Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang AngliKang Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang AngliKang Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Zhejiang AngliKang Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.


Zhejiang AngliKang Pharmaceutical Co  (SZSE:002940) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Zhejiang AngliKang Pharmaceutical Co EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Zhejiang AngliKang Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang AngliKang Pharmaceutical Co Ltd (SZSE:002940) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)
Comparable Companies
SHSE:603168 SZSE:000919 SZSE:301520 SHSE:603669 SZSE:000788 SZSE:002923 SHSE:688799 SHSE:603538 SZSE:002082 SZSE:301201 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 1000, North Luzhou Avenue, Zhejiang Province, Quzhou, CHN, 312400
Website
http://www.alkpharm.com
Zhejiang AngliKang Pharmaceutical Co Ltd is engaged in the manufacturing and sale of pharmaceutical materials, pharmaceutic preparations, and medical empty capsules. The main products offered by the group are cephalosporins antibacterial, angiocarpy drugs and gastrointestinal tract drugs. Geographically, the activities are carried out through Shengzhou, China.
Executives
Pan Xiao Yun Supervisors
Ye Shu Xiang Director
Yang Guo Dong Executives
Xu Ai Fang Supervisors
Wu Zhe Hua Director

Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) Headlines

No Headlines